Bionano Genomics, Inc.
BNGO • NASDAQ
Bionano Genomics, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Robert Erik Holmlin, with a market cap of $12.9M.
CEORobert Erik Holmlin
Next Earnings
Upcoming earnings announcement for Bionano Genomics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.88
Revenue Estimate
$7.2M
Earnings History
Past 12 earnings reports for Bionano Genomics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$0.77Est: -$2.81 | +72.6% | $8.0MEst: $7.9M | +0.8% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$1.59Est: -$2.13 | +25.4% | $7.4MEst: $6.9M | +7.3% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$1.99Est: -$2.87 | +30.7% | $6.7MEst: $6.6M | +2.6% | 10-Q |
| May 14, 2025 | Q1 2025 | -$1.15Est: -$3.49 | +67.0% | $6.5MEst: $6.3M | +3.2% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$12.22 | — | $8.2MEst: $6.2M | +31.7% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$31.20Est: -$12.60 | -147.6% | $6.1MEst: $7.9M | -22.6% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$14.40Est: -$25.20 | +42.9% | $7.8MEst: $8.0M | -2.9% | 10-Q |
| May 8, 2024 | Q1 2024 | -$36.00Est: -$38.40 | +6.2% | $8.8MEst: $8.5M | +3.3% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$57.60Est: -$52.20 | -10.3% | $10.7MEst: $10.6M | +1.3% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$60.60Est: -$56.40 | -7.4% | $9.3MEst: $9.0M | +3.8% | — |
| Aug 9, 2023 | Q2 2023 | -$74.40Est: -$61.80 | -20.4% | $8.7MEst: $8.3M | +4.5% | 10-Q |
| May 9, 2023 | Q1 2023 | -$72.00Est: -$66.00 | -9.1% | $7.4MEst: $7.4M | +0.7% | — |